Nanostim, which is backed by St. Jude Medical, raises $10 million for a leadless pacemaker designed to be implanted directly in the heart.
Nanostim, the Sunnyvale, Calif.-based company that’s developing a leadless pacemaker, raised $10 million in an equity and options deal, according to a regulatory filing.
